The EVEREST study: an international collaboration

Fergus J. Caskey, Vianda S. Stel, Robert F. Elliott, Kitty J. Jager, Adrian Covic, Ana Cusumano, Claudia Geue, Anneke Kramer, Benedicte Stengel, Alison Macleod

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Rates of initiation of renal replacement therapy (RRT), use of home modalities of treatment and patient outcomes vary considerably between countries. This paper reports the methods and baseline characteristics of countries participating in the EVEREST study (n = 46), a global collaboration examining the association between medical and non-medical factors and RRT incidence, modality mix and survival. Numbers of incident and prevalent patients were collected for current (2003–05) and historic (1983–85, 1988–90, 1993–95 and 1998–2000) periods stratified, where available, by age, gender, treatment modality and cause of end stage renal disease (diabetic versus non-diabetic). General population age and health indicators and national-level macroeconomic data were collected from secondary data sources. National experts provided primary data on renal service funding, resources and organization. The median (inter quartile range) RRT incidence per million of the population (pmp) was 130 pmp (102–167 pmp). The general population life expectancy at 60 was 22.1 years (19.7–23.1 years) and 6.9% had diabetes mellitus (5.4–9.0%). Healthcare spending as a percentage of gross domestic product was 8.1% (5.6–9.3%). Countries averaged nine dialysis facilities pmp (4–12 pmp), with 69.0% (43.9–99.0%) owned by the public or private not-for-profit sector. The number of nephrologists ranged from 0.5 to 48 pmp (median 12 pmp). The heterogeneity of EVEREST countries will enable modelling to examine the independent association between medical and non-medical factors on RRT epidemiology.
Original languageEnglish
Pages (from-to)28-36
Number of pages9
JournalNDT Plus
Volume3
Issue number1
Early online date19 Oct 2009
DOIs
Publication statusPublished - Feb 2010

Fingerprint

Renal Replacement Therapy
Population
Gross Domestic Product
Information Storage and Retrieval
Incidence
Life Expectancy
Chronic Kidney Failure
Dialysis
Diabetes Mellitus
Epidemiology
Organizations
Delivery of Health Care
Kidney
Survival
Health
Therapeutics

Keywords

  • dialysis
  • epidemiology and outcomes
  • risk factors

Cite this

Caskey, F. J., Stel, V. S., Elliott, R. F., Jager, K. J., Covic, A., Cusumano, A., ... Macleod, A. (2010). The EVEREST study: an international collaboration. NDT Plus, 3(1), 28-36. https://doi.org/10.1093/ndtplus/sfp146

The EVEREST study : an international collaboration. / Caskey, Fergus J.; Stel, Vianda S.; Elliott, Robert F.; Jager, Kitty J.; Covic, Adrian; Cusumano, Ana; Geue, Claudia; Kramer, Anneke; Stengel, Benedicte; Macleod, Alison.

In: NDT Plus, Vol. 3, No. 1, 02.2010, p. 28-36.

Research output: Contribution to journalArticle

Caskey, FJ, Stel, VS, Elliott, RF, Jager, KJ, Covic, A, Cusumano, A, Geue, C, Kramer, A, Stengel, B & Macleod, A 2010, 'The EVEREST study: an international collaboration', NDT Plus, vol. 3, no. 1, pp. 28-36. https://doi.org/10.1093/ndtplus/sfp146
Caskey FJ, Stel VS, Elliott RF, Jager KJ, Covic A, Cusumano A et al. The EVEREST study: an international collaboration. NDT Plus. 2010 Feb;3(1):28-36. https://doi.org/10.1093/ndtplus/sfp146
Caskey, Fergus J. ; Stel, Vianda S. ; Elliott, Robert F. ; Jager, Kitty J. ; Covic, Adrian ; Cusumano, Ana ; Geue, Claudia ; Kramer, Anneke ; Stengel, Benedicte ; Macleod, Alison. / The EVEREST study : an international collaboration. In: NDT Plus. 2010 ; Vol. 3, No. 1. pp. 28-36.
@article{e0ccb08314854a4e8b10b6c5dcc6db0e,
title = "The EVEREST study: an international collaboration",
abstract = "Rates of initiation of renal replacement therapy (RRT), use of home modalities of treatment and patient outcomes vary considerably between countries. This paper reports the methods and baseline characteristics of countries participating in the EVEREST study (n = 46), a global collaboration examining the association between medical and non-medical factors and RRT incidence, modality mix and survival. Numbers of incident and prevalent patients were collected for current (2003–05) and historic (1983–85, 1988–90, 1993–95 and 1998–2000) periods stratified, where available, by age, gender, treatment modality and cause of end stage renal disease (diabetic versus non-diabetic). General population age and health indicators and national-level macroeconomic data were collected from secondary data sources. National experts provided primary data on renal service funding, resources and organization. The median (inter quartile range) RRT incidence per million of the population (pmp) was 130 pmp (102–167 pmp). The general population life expectancy at 60 was 22.1 years (19.7–23.1 years) and 6.9{\%} had diabetes mellitus (5.4–9.0{\%}). Healthcare spending as a percentage of gross domestic product was 8.1{\%} (5.6–9.3{\%}). Countries averaged nine dialysis facilities pmp (4–12 pmp), with 69.0{\%} (43.9–99.0{\%}) owned by the public or private not-for-profit sector. The number of nephrologists ranged from 0.5 to 48 pmp (median 12 pmp). The heterogeneity of EVEREST countries will enable modelling to examine the independent association between medical and non-medical factors on RRT epidemiology.",
keywords = "dialysis, epidemiology and outcomes, risk factors",
author = "Caskey, {Fergus J.} and Stel, {Vianda S.} and Elliott, {Robert F.} and Jager, {Kitty J.} and Adrian Covic and Ana Cusumano and Claudia Geue and Anneke Kramer and Benedicte Stengel and Alison Macleod",
year = "2010",
month = "2",
doi = "10.1093/ndtplus/sfp146",
language = "English",
volume = "3",
pages = "28--36",
journal = "NDT Plus",
issn = "1753-0784",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - The EVEREST study

T2 - an international collaboration

AU - Caskey, Fergus J.

AU - Stel, Vianda S.

AU - Elliott, Robert F.

AU - Jager, Kitty J.

AU - Covic, Adrian

AU - Cusumano, Ana

AU - Geue, Claudia

AU - Kramer, Anneke

AU - Stengel, Benedicte

AU - Macleod, Alison

PY - 2010/2

Y1 - 2010/2

N2 - Rates of initiation of renal replacement therapy (RRT), use of home modalities of treatment and patient outcomes vary considerably between countries. This paper reports the methods and baseline characteristics of countries participating in the EVEREST study (n = 46), a global collaboration examining the association between medical and non-medical factors and RRT incidence, modality mix and survival. Numbers of incident and prevalent patients were collected for current (2003–05) and historic (1983–85, 1988–90, 1993–95 and 1998–2000) periods stratified, where available, by age, gender, treatment modality and cause of end stage renal disease (diabetic versus non-diabetic). General population age and health indicators and national-level macroeconomic data were collected from secondary data sources. National experts provided primary data on renal service funding, resources and organization. The median (inter quartile range) RRT incidence per million of the population (pmp) was 130 pmp (102–167 pmp). The general population life expectancy at 60 was 22.1 years (19.7–23.1 years) and 6.9% had diabetes mellitus (5.4–9.0%). Healthcare spending as a percentage of gross domestic product was 8.1% (5.6–9.3%). Countries averaged nine dialysis facilities pmp (4–12 pmp), with 69.0% (43.9–99.0%) owned by the public or private not-for-profit sector. The number of nephrologists ranged from 0.5 to 48 pmp (median 12 pmp). The heterogeneity of EVEREST countries will enable modelling to examine the independent association between medical and non-medical factors on RRT epidemiology.

AB - Rates of initiation of renal replacement therapy (RRT), use of home modalities of treatment and patient outcomes vary considerably between countries. This paper reports the methods and baseline characteristics of countries participating in the EVEREST study (n = 46), a global collaboration examining the association between medical and non-medical factors and RRT incidence, modality mix and survival. Numbers of incident and prevalent patients were collected for current (2003–05) and historic (1983–85, 1988–90, 1993–95 and 1998–2000) periods stratified, where available, by age, gender, treatment modality and cause of end stage renal disease (diabetic versus non-diabetic). General population age and health indicators and national-level macroeconomic data were collected from secondary data sources. National experts provided primary data on renal service funding, resources and organization. The median (inter quartile range) RRT incidence per million of the population (pmp) was 130 pmp (102–167 pmp). The general population life expectancy at 60 was 22.1 years (19.7–23.1 years) and 6.9% had diabetes mellitus (5.4–9.0%). Healthcare spending as a percentage of gross domestic product was 8.1% (5.6–9.3%). Countries averaged nine dialysis facilities pmp (4–12 pmp), with 69.0% (43.9–99.0%) owned by the public or private not-for-profit sector. The number of nephrologists ranged from 0.5 to 48 pmp (median 12 pmp). The heterogeneity of EVEREST countries will enable modelling to examine the independent association between medical and non-medical factors on RRT epidemiology.

KW - dialysis

KW - epidemiology and outcomes

KW - risk factors

U2 - 10.1093/ndtplus/sfp146

DO - 10.1093/ndtplus/sfp146

M3 - Article

VL - 3

SP - 28

EP - 36

JO - NDT Plus

JF - NDT Plus

SN - 1753-0784

IS - 1

ER -